These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21034830)

  • 1. Protective effect of immunosuppressive treatment before orthotopic kidney autotransplantation.
    Cicora F; Lausada N; Vasquez DN; Cicora P; Guerrieri D; Gonzalez P; Zalazar G; Stringa P; Raimondi C
    Transpl Immunol; 2011 Jan; 24(2):107-12. PubMed ID: 21034830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus in kidney transplant donors and clinical and histologic improvement in recipients: rat model.
    Cicora F; Lausada N; Vasquez DN; Cicora P; Zalazar G; Gonzalez P; Palti G; Raimondi C
    Transplant Proc; 2010; 42(1):365-70. PubMed ID: 20172351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.
    Cicora F; Roberti J; Vasquez D; Guerrieri D; Lausada N; Cicora P; Palti G; Chuluyan E; Gonzalez P; Stringa P; Raimondi C
    Clin Exp Immunol; 2012 Jan; 167(1):169-77. PubMed ID: 22132896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression].
    Cicora F; Roberti J; Lausada N; González P; Guerrieri D; Stringa P; Raimondi C
    Medicina (B Aires); 2012; 72(1):3-9. PubMed ID: 22257448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
    Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
    Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor preconditioning with rabbit anti-rat thymocyte immunoglobulin ameliorates ischemia reperfusion injury in rat kidney transplantation.
    Cicora F; Roberti J; Lausada N; González P; Guerrieri D; Stringa P; Cicora P; Vásquez D; González I; Palti G; Intile D; Raimondi C
    Transpl Immunol; 2012 Aug; 27(1):1-7. PubMed ID: 22484297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of heme oxygenase 1 in rapamycin-induced renal dysfunction after ischemia and reperfusion injury.
    Gonçalves GM; Cenedeze MA; Feitoza CQ; Wang PM; Bertocchi AP; Damião MJ; Pinheiro HS; Antunes Teixeira VP; dos Reis MA; Pacheco-Silva A; Câmara NO
    Kidney Int; 2006 Nov; 70(10):1742-9. PubMed ID: 17003813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal function and histology in kidney transplant patients receiving tacrolimus and sirolimus or mycophenolate mofetil.
    Kamar N; Van TT; Ribes D; Modesto A; Cointault O; Lavayssière L; Ader JL; Durand D; Rostaing L
    Exp Clin Transplant; 2006 Dec; 4(2):532-6. PubMed ID: 17238854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for HO-1 in renal function impairment in animals subjected to ischemic and reperfusion injury and treated with immunosuppressive drugs.
    Feitoza CQ; Gonçalves GM; Bertocchi AP; Wang PW; Damião MJ; Cenedeze MA; Teixeira VP; Dos Reis MA; Pacheco-Silva A; Câmara NO
    Transplant Proc; 2007 Mar; 39(2):424-6. PubMed ID: 17362747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):252-8. PubMed ID: 14742990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.
    Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A
    BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immunosuppression with tacrolimus and mycophenolate mofetil on renal histology and function in single kidney rats submitted to ischemia and reperfusion.
    Dias PH; Oliveira GA; Dias FG; Gomes Rde P; Tambara Filho R; Fraga Rd
    Acta Cir Bras; 2015 Feb; 30(2):127-33. PubMed ID: 25714692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors.
    Reutzel-Selke A; Zschockelt T; Denecke C; Bachmann U; Jurisch A; Pratschke J; Schmidbauer G; Volk HD; Neuhaus P; Tullius SG
    Transplantation; 2003 Jun; 75(11):1786-92. PubMed ID: 12811235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic training and immunosuppressive agents reduce the intensity of ischemic reperfusion injury after kidney transplantation.
    Treska V; Molacek J; Kobr J; Racek J; Trefil L; Hes O
    Exp Clin Transplant; 2006 Jun; 4(1):439-44. PubMed ID: 16827640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.
    Loverre A; Ditonno P; Crovace A; Gesualdo L; Ranieri E; Pontrelli P; Stallone G; Infante B; Schena A; Di Paolo S; Capobianco C; Ursi M; Palazzo S; Battaglia M; Selvaggi FP; Schena FP; Grandaliano G
    J Am Soc Nephrol; 2004 Oct; 15(10):2675-86. PubMed ID: 15466272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids.
    Glotz D; Charpentier B; Abramovicz D; Lang P; Rostaing L; Rifle G; Vanrenterghem Y; Berthoux F; Bourbigot B; Delahousse M; Chalopin JM; Cassuto E; Lefrançois N
    Transplantation; 2010 Jun; 89(12):1511-7. PubMed ID: 20386144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model.
    Martinez-Palli G; Hirose R; Liu T; Xu F; Dang K; Feiner J; Serkova NJ; Niemann CU
    Nephrol Dial Transplant; 2011 Jun; 26(6):1813-20. PubMed ID: 21068143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.